Wyeth Articles
Wyeth submits BLA for Prevnar 13
2 April 2009
GSK's Synflorix approved in Europe
1 April 2009
Saudi Arabia is 35th Prevenar nation
31 March 2009
Japan stock market week to March 23, 2009
30 March 2009
FDA appros new use for Wyeth's Tygacil
30 March 2009
Pfizer completes $13.5M debt offering
30 March 2009
Sutent cleared for UK kidney cancer patients
30 March 2009
Takeda recovers UK Prostap rights from Wyeth
30 March 2009
Retail drug sales in year to December 2008
30 March 2009
Lyrica fares well vs venlafaxine-ER in GAD
30 March 2009
Impax to co-promote Wyeth's Pristiq
30 March 2009
Ablynx' loss deepens 21.6% to 14.3M euros
23 March 2009
Pfizer sells bonds to cover Wyeth debts
23 March 2009
Data on withdrawn drugs was faked; says hospital
16 March 2009
EC OKs Wyeth ReFacto MA variation
16 March 2009
Pre-emption is
16 March 2009
Adlyfe signs AD deal with Wyeth
2 March 2009
Analysts expect profit for Theravance in 2012
2 March 2009
Llamas way forward for antibody drugs
23 February 2009
Stock Commentary - Europe - week to Feb 16, 2009
23 February 2009
Crucell back in profit as Wyeth deal collapses
16 February 2009
Sutent available in England, not Scotland
9 February 2009
Stock Commentary - New York week to Feb 2, 2009
9 February 2009
Stock Commentary - Europe - week to Feb 2, 2009
9 February 2009
Lilly swings to loss on ImClone acquisition
9 February 2009
Lexapro and Zoloft are "best" antidepressants
9 February 2009
Retail drug sales in year to November 2008
26 January 2009
Arthritis care costs Australia A$24B/year
26 January 2009
Turkey adds Wyeth
19 January 2009
Stock Commentary - Europe - week to Jan 19, 2009
19 January 2009
Prism gets FDA app for Nexterone injection
19 January 2009
Wyeth invests $10M in Santaris under LNA deal
19 January 2009
Wyeth in talks to acquire Crucell; sources say potential offer could be up to $1.35B
12 January 2009
GSK gets FDA complete response for Eurand drug
12 January 2009
Wyeth buys UK biotech Thiakis for $150M
12 January 2009
Wyeth in US Senate ghostwriting probe
22 December 2008
Wyeth's neratinib plus Herceptin yields 60% PFS rate
22 December 2008
Retail drug sales in year to October 2008
22 December 2008
Rib-X
15 December 2008
Scottish regulators give nod to Bayer's Xarelto, Wyeth's Relistor and B-MS' Reyataz
15 December 2008
Wyeth presents new Enbrel PA data
15 December 2008
Indonesia tells drug firms: "invest or go"
8 December 2008
Strong Ph III for Relistor in non-cancer OIC
8 December 2008
Wyeth promotes Michael Kamarck to president of TO & PS
1 December 2008
Wyeth Canada names Christian Velmer as president
1 December 2008
Good news for Wyeth from CHMP
1 December 2008
Progenics gets Australian appro for Relistor
24 November 2008
Mylan gets US appro for generic Effexor
24 November 2008
Lasting benefits of CEL-SCI's RA vaccine demonstrated
24 November 2008
Democrat legislative triple-lock threat to US pharma: prospects of the Obama presidency
24 November 2008
TorreyPines confirms Evelyn Graham as CEO
17 November 2008
Retail drug sales in year to September 2008
17 November 2008
Biovitrum and Wyeth extend ReFacto supply deal
17 November 2008
FDA pre-emption case: "verdict in 2009"
10 November 2008
Sun Pharma's fiscal 2nd-qtr profit soars 135%
10 November 2008
Wyeth welcomes NICE review of Torisel
10 November 2008
Landmark case at US Supreme Court
3 November 2008
Wyeth presents on two Ph IV AS trials of Enbrel
3 November 2008
Wyeth's PCV13 may offer broader protection than Prevnar
3 November 2008
Finland's Biotie to acquire elbion GmbH
3 November 2008
Wyeth's 3rd-qtr profit flat; AD drug delayed
3 November 2008
EMEA's PDCO thumbs-up to eight PIPs
3 November 2008
Ono licenses Progenics' OIC drug in Japan
27 October 2008
Wyeth pulls European MAA for desvenlafaxine
20 October 2008
Retail drug sales in year to August 2008
20 October 2008
Japan stock market week to Oct 13, 2008
20 October 2008
Japan MHLW Study C'ttee views developments
13 October 2008
US and UK Prix Galien awards 2008, winners announced
6 October 2008
Wyeth/ALS deal for antibiotic in Asia/Pac
6 October 2008
Wyeth replaces Japanese president with Michael Goettler
6 October 2008
SPD Minister attacks Germany's drugmakers
29 September 2008
CLARIFICATION: Wyeth's Viviant Ph III trial
29 September 2008
Wyeth's Enbrel could help QoL in psoriasis
29 September 2008
UPDATE: Wyeth's Viviant fails to match Lilly's Evista
22 September 2008
Pfizer economic study says Sutent cost effective in mRCC
22 September 2008
Retail drug sales in year to July 2008
22 September 2008
Wyeth's Viviant fails to match Lilly's Evista
22 September 2008
South Africa starts Prevenar program
22 September 2008
Ligand to settle dispute with Salk Institute
15 September 2008
Cyprus and Ireland add Wyeth's Prevenar to immunization schedules
15 September 2008
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
